Tañeza, Baby Girl .
HRN: 28-92-61 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/04/2026
AMPICILLIN 250MG (VIAL)
05/04/2026
05/10/2026
IVT
115mg
Q12H
NAMF (PROM X 24 Hours)
Checking Initial Appropriateness
05/04/2026
GENTAMICIN 40MG/ML, 2ML (AMP)
05/04/2026
05/10/2026
IVT
11mg
Q24H
NAMF (PROM X 24 Hours)
Checking Initial Appropriateness